GABRB2 and depressive disorder: The decreased depression-like behavior in the tail-suspension and sucrose-preference tests, and anxiety-like behavior in the elevated-plus maze in Gabrb2-knockout mice (Fig. 1a–c), indicated a separation of the schizophrenia type symptoms from comorbid affective symptoms.